Alexander Burnett

Sourced from institutional research profiles (UAMS TRI or ARA).

High Impact

Researcher

UAMS primary University of Arkansas

Also affiliated: University of Southern California (1998–2007); Gynecologic Oncology Group (2005–2007); Children's Hospital of Los Angeles (2000–2004); Georgetown University (1992–1994); University of Arkansas Medical Center (2004–2024); Georgetown University Medical Center (1992–1994); Glasgow Royal Infirmary (1986); Ruchill Hospital (1986); Feed Control (Norway) (2006); USC Norris Comprehensive Cancer Center (2000); Winthrop Rockefeller Foundation (2018–2024); Washington Center (1994); Beijing Obstetrics and Gynecology Hospital (2007); University of Brescia (2006)

Faculty Researcher

31 h-index 79 pubs 3,588 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Alexander Burnett's research focuses on the application and advancement of vaginal natural orifice transluminal endoscopic surgery (vNOTES) for gynecologic procedures, including gynecologic oncology. His work has involved developing and reporting on new approaches to complex surgeries, such as radical hysterectomy for cervical cancer and retroperitoneal sentinel lymph node dissection for endometrial cancer staging.

Burnett has conducted case series and studies investigating the feasibility and outcomes of vNOTES in specific patient populations, including women with morbid and super-morbid obesity. His publications also extend to the molecular mechanisms driving disease proliferation, such as the role of microRNA-21 in lymphatic malformation endothelial cells. He leads a research group and has a publication record of 79 works with 3,569 citations, achieving an h-index of 30, and is recognized as a highly cited researcher.

Metrics

h-index: 31
Publications: 79
Citations: 3,588

Selected Publications

Comparison of cost of endometrial cancer staging between robotic and vNOTES techniques (2026)

Gynecologic Oncology DOI OpenAlex
A pilot study utilizing hypothermia to reduce chemotherapy-induced peripheral neuropathy (2026)

Gynecologic Oncology DOI OpenAlex
Cochlear Implantation Outcomes in Paget’s Disease of the Bone: A Systematic Review (2026)

Otology & Neurotology DOI OpenAlex
Rescue of Angiopoietin‐2 Inhibits Proliferation of Lymphatic Malformation Endothelial Cells (2025)

The FASEB Journal 1 citation DOI OpenAlex
A Systematic Review of Case Reports of Spontaneous Retropharyngeal Hematoma (2025)

Laryngoscope Investigative Otolaryngology DOI OpenAlex
vNOTES retroperitoneal sentinel lymph node dissection for endometrial cancer staging: First multicenter international prospective case series (2024)

Gynecologic Oncology DOI OpenAlex
vNOTES retroperitoneal sentinel lymph node dissection for endometrial cancer staging: First multicenter, prospective case series (2024)

Acta Obstetricia Et Gynecologica Scandinavica 30 citations DOI OpenAlex
vNOTES (vaginal natural orifice transluminal surgery) gynecologic procedures in morbidly and super-morbidly obese women: five year experience (2023)

Archives of Gynecology and Obstetrics 21 citations DOI OpenAlex
VNOTES (Vaginal Natural Orifice Transluminal Surgery) Gynecologic Procedures in Morbidly and Super-morbidly Obese Women: Five Year Experience for Three Surgeons (2023)

Research Square DOI OpenAlex
A new approach to radical hysterectomy: First report of treatment via vNOTES for cervical cancer (2022)

Asian Journal of Surgery 11 citations DOI OpenAlex
VNOTES (vaginal natural orifice transluminal endoscopic surgery) staging of endometrial cancer with sentinel lymph nodes (551) (2022)

Gynecologic Oncology DOI OpenAlex
Vaginal Natural Orifice Transluminal Endoscopic Surgery for Gynecologic and Gynecologic Oncology Procedures (2021)

IntechOpen eBooks 4 citations DOI OpenAlex
Radiation treatment for refractory endometriosis: a 38-year-old female presenting with vaginal bleeding (2021)

Reports of Practical Oncology & Radiotherapy 2 citations DOI OpenAlex
Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) for Low-grade Endometrial Cancer: The First Fifty Patients (2021)

1 citation DOI OpenAlex
Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells (2020)

Reproductive Sciences 23 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

OUHSC/GYN ONC GROUP CFDA 93-395 (Pamela Stone, PI) GOG 0240 A RANDOMIZED PHASE III TRIAL OF CISPLATIN PLUS PACLITAXEL WITH AND WITHOUT NCI-SUPPLIED BE NIH/Nat. Cancer Institute via University of Oklahoma Health Sciences Center
Evaluation of Multiple Biomarker Assays to Estimate Risk of Ovarian Cancer in Patients Presenting with a Pelvic Mass Fujirebio Diagnostics, Inc
2004-27: A Phase I / II Study to Evaluate the Safety, Tolerance, and Efficacy of RSR13 (efaproxiral) Administered to Patients Receiving a Course of Ci Allos Therapeutics, Inc.
Spectroscopic Evaluation of Cervical Neoplasia Guided Therapeutics
AP 23573-07-205 A Randomized phase II trial of deforolimus (AP23573; MK-8669) compared to progestin in female adult patients with advanced endometrial ARIAD Pharmaceutical
Protocol B9E-US-S302, Phase III Randomized Trial of Induction Chemotherapy with Gemcitabine and Carboplatin Followed by Paclitaxel Consolidation versu Lilly Research Laboratories
Oral Interleukin 11 as a Countermeasure against Radiation Injury to Gut NIH
A Randomized, Double-Blind, PlaceboControlled, Multicenter, 18 Week Pilot Study to Investigate the Neuroprotective Effect of Procrit® (Epoetin Alfa) o Ortho Biotech Products, L.P.